Talon Resources Targets Ontario Gold Growth After AIM Move and Eagle Lake Acquisition, CEO Says.Watch here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksHill & Smith Regulatory News (HILS)

Share Price Information for Hill & Smith (HILS)

Share Price is delayed by 15 minutes
Get Live Data
2790.00    -15.00 (-0.53%)
Bid:
2785.00
Ask:
2790.00
Spread: 5.00 (0.18%)
Market Cap: £2.18b
HILS Live PriceLast checked at - London Stock Exchange

Intraday Hill & Smith Share Chart

Director/PDMR Shareholding

27 May 2026 15:01

RNS Number : 9325F
Hill & Smith PLC
27 May 2026
 

 

Hill & Smith PLC

(the 'Company' or 'Hill & Smith')

 

Director / PDMR Shareholding

 

Hill & Smith announces that on 26 May 2026, it was notified of the exercise and subsequent sale by Chris McLeish, Chief Financial Officer of Shares under his 2023 Deferred Bonus Buy-Out Award.

 

The Notification of Dealing Form can be found below:

 

1.

Details of the person discharging managerial responsibilities/person closely associated

(a)

Name

Chris McLeish

2.

Reason for the notification

(a)

Position/status

Chief Financial Officer

(b)

Initial notification/ Amendment

Initial notification

3.

Details of the issuer

(a)

Name

Hill & Smith PLC

(b)

LEI

2138003A3ISGQZBOWI83

4.1

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

(a)

Description of the Financial Instrument

Ordinary Shares of £0.25 each

(b)

Identification code of the Financial Instrument

GB0004270301

(c)

Nature of the transaction

Acquisition of Ordinary Shares pursuant to the exercise of an award under his 2023 Deferred Bonus Buy-Out Award.

(d)

Price(s) and volume(s)

Price(s)

Volume(s)

Nil

 

5,690

(e)

Aggregated information

N/A

- Aggregated volume

- Price

(f)

Date of the transaction

26 May 2026

(g)

Place of the transaction

Outside of a trading venue

4.2

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

(a)

Description of the Financial Instrument

Ordinary Shares of £0.25 each

(b)

Identification code of the Financial Instrument

GB0004270301

(c)

Nature of the transaction

Sale of Ordinary Shares to cover tax and NI liability on the exercise of awards outlined in 4.1.

(d)

Price(s) and volume(s)

Price(s)

Volume(s)

£27.60

 

2,682

(e)

Aggregated information

N/A

- Aggregated volume

- Price

(f)

Date of the transaction

26 May 2026

(g)

Place of the transaction

XLON

 

Enquiries:

 

Karen Atterbury

Company Secretary

0121 704 7430

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
DSHAKOBKQBKDKPB
Date   Source Headline
3rd May 20114:43 pmRNSTotal Voting Rights
28th Apr 20118:36 amRNSHolding(s) in Company
19th Apr 20113:36 pmRNSAnnual Information Update
8th Apr 20113:03 pmRNSHolding(s) in Company
1st Apr 20114:00 pmRNSAnnual Report & Accounts and AGM Notice
21st Mar 20112:42 pmRNSDirector/PDMR Shareholding
16th Mar 20114:36 pmRNSCompletion of Acquisition
11th Mar 201110:54 amRNSDirector/PDMR Shareholding
9th Mar 20117:00 amRNSAcquisition
9th Mar 20117:00 amRNSFinal Results
7th Mar 20118:10 amRNSHolding(s) in Company
17th Feb 20119:54 amRNSTR1: Notification of Major Interest in Shares
11th Feb 20119:29 amRNSHolding(s) in Company
4th Feb 20117:00 amRNSAppointment of Broker and Financial Adviser
20th Jan 20111:21 pmRNSChange of Preliminary Results Announcement Date
17th Jan 20119:56 amRNSBlocklisting Interim Review
12th Jan 20117:00 amRNSNotice of Results
1st Dec 20107:00 amRNSTotal Voting Rights
22nd Nov 20103:46 pmRNSDirector's Additional Appointment
16th Nov 20107:00 amRNSDirector/PDMR Shareholding
11th Nov 20107:00 amRNSInterim Management Statement
1st Nov 201011:00 amRNSNotice of Interim Management Statement
29th Oct 201011:59 amRNSTotal Voting Rights
27th Sep 20103:53 pmRNSMajor shareholding: Correcting Announcement
13th Aug 20107:00 amRNSPublication of Interim Report
13th Aug 20107:00 amRNSHolding(s) in Company
9th Aug 20107:00 amRNSHalf Yearly Report
22nd Jul 201012:31 pmRNSHolding(s) in Company
19th Jul 201010:09 amRNSBlocklisting - Six Monthly Return
14th Jul 201012:00 pmRNSNotice of Interim Results
1st Jul 20101:18 pmRNSTotal Voting Rights
18th Jun 201011:19 amRNSHolding(s) in Company
1st Jun 20109:55 amRNSTotal Voting Rights
21st May 201012:30 pmRNSDirector/PDMR Shareholding
10th May 201011:29 amRNSDirector/PDMR Shareholding
10th May 201010:47 amRNSDirector/PDMR Shareholding
7th May 20101:42 pmRNSResult of AGM
7th May 20107:00 amRNSInterim Management Statement
5th May 20107:00 amRNSRe Contract
4th May 201011:39 amRNSTotal Voting Rights
22nd Apr 20103:02 pmRNSHolding(s) in Company
9th Apr 201012:00 pmRNSAnnual Information Update
8th Apr 20109:57 amRNSDirector's Additional Appointment
7th Apr 201011:09 amRNSAnnual Report and Accounts
6th Apr 20102:42 pmRNSDirector/PDMR Shareholding
1st Apr 20102:53 pmRNSDirector/PDMR Shareholding
1st Apr 201010:00 amRNSTotal Voting Rights
23rd Mar 201012:20 pmRNSHolding(s) in Company
9th Mar 20107:00 amRNSAnnual Results
1st Mar 201010:38 amRNSVoting Rights and Capital

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.